Highlander Capital Management, LLC - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
Highlander Capital Management, LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2013$12,850,000
+32.5%
5,0000.0%0.01%
+30.0%
Q2 2013$9,700,0005,0000.01%
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Callan Capital, LLC 70,000$65,0000.02%
Wellington Shields Capital Management, LLC 51,000$47,0000.01%
Ifrah Financial Services, Inc. 18,500$17,0000.01%
CHELSEA COUNSEL CO 28,000$26,0000.01%
DRW Securities, LLC 120,000$111,0000.01%
TUDOR INVESTMENT CORP ET AL 66,303$61,0000.00%
OPPENHEIMER & CO INC 107,000$99,0000.00%
First Allied Advisory Services, Inc. 45,000$42,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$65,0000.00%
GROUP ONE TRADING, L.P. 160,103$148,0000.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders